|
WO2011153592A1
|
|
Therapeutic molecules
|
|
WO2011100792A1
|
|
Protein biomarkers for obstructive airways diseases
|
|
EP2440238A1
|
|
Methods of treatment
|
|
EP2217626A1
|
|
Epitope for neutralizing antibodies
|
|
EP2217273A1
|
|
Methods and compositions for regulating airway tissue remodelling
|
|
AU2008253608A1
|
|
Neutralizing antibodies
|
|
WO2008116267A1
|
|
Therapeutic targets and molecules
|
|
US2011129845A1
|
|
Method of diagnosis
|
|
WO2007087689A1
|
|
A method of modulating cellular activity and agents for use therein
|
|
CA2568708A1
|
|
Method for evaluating asthma control
|
|
AU2006241300A1
|
|
Method for evaluating asthma control
|
